Rahul Lall

Bio/CV: 

Wearable Integrated Sparse-SPECT for Cancer Radiotherapy

Radiopharmaceutical therapy (RPT) has recently shown promise in the treatment of neuroendocrine and prostate cancer, giving hope to late stage metastatic cancer patients that currently have very few treatment options. RPT involves conjugating a radioisotope to a cancer specific molecule, which is subsequently intravenously administered to selectively target cancer cells anywhere in the body while sparing most normal tissues. Currently, there is no method for continuous, real-time monitoring of the biokinetics of this radiopharmaceutical to optimize and maximize the radiation dose to the tumors while ensuring minimal dose is delivered to healthy organs to prevent toxicity. I am working on developing a wearable network of single gamma photon-sensitive ICs and sparse dose reconstruction methodology to enable a high temporal resolution imaging system for RPT personalization.

Research interests: 

Expected Graduation Date:

May, 2027

Role: 

Publications

Rahul Lall; Ali Niknejad; Mekhail Anwar; Youngho Seo
Conference Paper, 2025
Rahul Lall; Kyoungtae Lee; Adam Cunha; Rebecca Abergel; Youngho Seo; Ali Niknejad; Mekhail Anwar
Conference Paper, 2024